Colitis- Companies Involved in Therapeutics Development, Scope 2019

Posted on 2019-10-01 by Mark Hub in Pharmaceuticals // 0 Comments

Albany, US, 2019-Oct-01 — /EPR Network/ —Market Research Hub (MRH) has actively included a new research study titled “Colitis-Pipeline Review, H2 2019” to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period until 2019. In addition, a deep analysis of the competitive landscape,including prime market players is also enclosed in this report.

Get Sample Copy at https://www.marketresearchhub.com/enquiry.php?type=S&repid=2519483

Colitis – Pipeline Review, H2 2019

Summary

Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Colitis – Pipeline Review, H2 2019, provides an overview of the Colitis (Gastrointestinal) pipeline landscape.

Colitis is swelling (inflammation) of the large intestine (colon). Colitis can have many different causes, including infections, including those caused by a virus, parasite, and food poisoning due to bacteria, inflammatory disorders (ulcerative colitis and Crohn’s disease), lack of blood flow (ischemic colitis), past radiation to the large bowel). Symptoms can include abdominal pain, bloating, bloody stools, chills, dehydration, diarrhea and fever. Treatment includes non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids.

Report Highlights

Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Colitis – Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Colitis (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Colitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Colitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase I, Preclinical and Unknown stages are 1, 2, 26 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 7 molecules, respectively.

Colitis (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Colitis (Gastrointestinal).
– The pipeline guide reviews pipeline therapeutics for Colitis (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Colitis (Gastrointestinal) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Colitis (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Colitis (Gastrointestinal)

Browse Complete Report at https://www.marketresearchhub.com/report/colitis-pipeline-review-h2-2019-report.html

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Colitis – Overview
Colitis – Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Colitis – Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Colitis – Companies Involved in Therapeutics Development
AlfaSigma SpA
Apollo Endosurgery Inc
Concenter BioPharma Silkim Ltd
enGene Inc
Genfit SA
Handa Pharmaceuticals LLC
Immodulon Therapeutics Ltd
Immuron Ltd
Inflazome Ltd
Nippon Kayaku Co Ltd
Principia Biopharma Inc
Protagonist Therapeutics Inc
RDD Pharma Ltd
Scholar Rock Inc
Soligenix Inc
Symbiotix Biotherapies Inc
Synthetic Biologics Inc
Vitality Biopharma Inc
Colitis – Drug Profiles
AcTMP-1 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BC-1215 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drugs to Antagonize TRP Channel for Inflammatory Diseases and Colitis – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
dusquetide – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
elafibranor – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Fusion Proteins for Colitis and Hypertension – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gene Therapy to Activate PD-L1 for Colitis and Graft Versus Host Disease – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GFC-101 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HND-016 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IMM-124E – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IMM-201 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MAK-11049 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MCC-950 – Drug Profile
Product Description
Mechanism Of Action

Continued………#@

Make an Enquiry about This Report https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=2519483

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like Pharmaceuticals market research and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick